Literature DB >> 33673439

The CD44high Subpopulation of Multifraction Irradiation-Surviving NSCLC Cells Exhibits Partial EMT-Program Activation and DNA Damage Response Depending on Their p53 Status.

Margarita Pustovalova1, Lina Alhaddad1, Taisia Blokhina1,2,3, Nadezhda Smetanina1,2, Anna Chigasova1,4, Roman Chuprov-Netochin1, Petr Eremin5, Ilmira Gilmutdinova5, Andreyan N Osipov1,2,3, Sergey Leonov1,6.   

Abstract

Ionizing radiation (IR) is used for patients diagnosed with unresectable non-small cell lung cancer (NSCLC). However, radiotherapy remains largely palliative due to the survival of specific cell subpopulations. In the present study, the sublines of NSCLC cells, A549IR (p53wt) and H1299IR (p53null) survived multifraction X-ray radiation exposure (MFR) at a total dose of 60 Gy were investigated three weeks after the MFR course. We compared radiosensitivity (colony formation), expression of epithelial-mesenchymal transition (EMT) markers, migration activity, autophagy, and HR-dependent DNA double-strand break (DSB) repair in the bulk and entire CD44high/CD166high CSC-like populations of both parental and MFR survived NSCLC cells. We demonstrated that the p53 status affected: the pattern of expression of N-cadherin, E-cadherin, Vimentin, witnessing the appearance of EMT-like phenotype of MFR-surviving sublines; 1D confined migratory behavior (wound healing); the capability of an irradiated cell to continue to divide and form a colony of NSCLC cells before and after MFR; influencing the CD44/CD166 expression level in MFR-surviving NSCLC cells after additional single irradiation. Our data further emphasize the impact of p53 status on the decay of γH2AX foci and the associated efficacy of the DSB repair in NSCLC cells survived after MFR. We revealed that Rad51 protein might play a principal role in MFR-surviving of p53 null NSCLC cells promoting DNA DSB repair by homologous recombination (HR) pathway. The proportion of Rad51 + cells elevated in CD44high/CD166high population in MFR-surviving p53wt and p53null sublines and their parental cells. The p53wt ensures DNA-PK-mediated DSB repair for both parental and MFR-surviving cells irrespectively of a subsequent additional single irradiation. Whereas in the absence of p53, a dose-dependent increase of DNA-PK-mediated non-homologous end joining (NHEJ) occurred as an early post-irradiation response is more intensive in the CSC-like population MFR-surviving H1299IR, compared to their parental H1299 cells. Our study strictly observed a significantly higher content of LC3 + cells in the CD44high/CD166high populations of p53wt MFR-surviving cells, which enriched the CSC-like cells in contrast to their p53null counterparts. The additional 2 Gy and 5 Gy X-ray exposure leads to the dose-dependent increase in the proportion of LC3 + cells in CD44high/CD166high population of both parental p53wt and p53null, but not MFR-surviving NSCLC sublines. Our data indicated that autophagy is not necessarily associated with CSC-like cells' radiosensitivity, emphasizing that careful assessment of other milestone processes (such as senescence and autophagy-p53-Zeb1 axis) of primary radiation responses may provide new potential targets modulated for therapeutic benefit through radiosensitizing cancer cells while rescuing normal tissue. Our findings also shed light on the intricate crosstalk between autophagy and the p53-related EMT, by which MFR-surviving cells might obtain an invasive phenotype and metastatic potential.

Entities:  

Keywords:  Rad51; cancer stem cells; epithelial-to-mesenchymal transition; non-small cell lung cancer; p53; radioresistance

Mesh:

Substances:

Year:  2021        PMID: 33673439      PMCID: PMC7956695          DOI: 10.3390/ijms22052369

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  103 in total

1.  Pathways of DNA double-strand break repair during the mammalian cell cycle.

Authors:  Kai Rothkamm; Ines Krüger; Larry H Thompson; Markus Löbrich
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

2.  Differential Radiation Sensitivity in p53 Wild-Type and p53-Deficient Tumor Cells Associated with Senescence but not Apoptosis or (Nonprotective) Autophagy.

Authors:  Jingwen Xu; Nipa H Patel; Tareq Saleh; Emmanuel K Cudjoe; Moureq Alotaibi; Yingliang Wu; Santiago Lima; Adam M Hawkridge; David A Gewirtz
Journal:  Radiat Res       Date:  2018-08-22       Impact factor: 2.841

Review 3.  Regulation of DNA double-strand break repair pathway choice.

Authors:  Meena Shrivastav; Leyma P De Haro; Jac A Nickoloff
Journal:  Cell Res       Date:  2008-01       Impact factor: 25.617

4.  Autophosphorylation of the catalytic subunit of the DNA-dependent protein kinase is required for efficient end processing during DNA double-strand break repair.

Authors:  Qi Ding; Yeturu V R Reddy; Wei Wang; Timothy Woods; Pauline Douglas; Dale A Ramsden; Susan P Lees-Miller; Katheryn Meek
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

5.  Rad51 overexpression contributes to chemoresistance in human soft tissue sarcoma cells: a role for p53/activator protein 2 transcriptional regulation.

Authors:  Jonathan A F Hannay; Juehui Liu; Quan-Sheng Zhu; Svetlana V Bolshakov; Lan Li; Peter W T Pisters; Alexander J F Lazar; Dihua Yu; Raphael E Pollock; Dina Lev
Journal:  Mol Cancer Ther       Date:  2007-05       Impact factor: 6.261

6.  Activation of meiosis-specific genes is associated with depolyploidization of human tumor cells following radiation-induced mitotic catastrophe.

Authors:  Fiorenza Ianzini; Elizabeth A Kosmacek; Elke S Nelson; Eleonora Napoli; Jekaterina Erenpreisa; Martins Kalejs; Michael A Mackey
Journal:  Cancer Res       Date:  2009-03-03       Impact factor: 12.701

7.  Acquired resistance to tyrosine kinase inhibitors may be linked with the decreased sensitivity to X-ray irradiation.

Authors:  Maxim Sorokin; Roman Kholodenko; Anna Grekhova; Maria Suntsova; Margarita Pustovalova; Natalia Vorobyeva; Irina Kholodenko; Galina Malakhova; Andrew Garazha; Artem Nedoluzhko; Raif Vasilov; Elena Poddubskaya; Olga Kovalchuk; Leila Adamyan; Vladimir Prassolov; Daria Allina; Denis Kuzmin; Kirill Ignatev; Andreyan Osipov; Anton Buzdin
Journal:  Oncotarget       Date:  2017-12-27

8.  RAD51 Is a Selective DNA Repair Target to Radiosensitize Glioma Stem Cells.

Authors:  Harry O King; Tim Brend; Helen L Payne; Alexander Wright; Thomas A Ward; Karan Patel; Teklu Egnuni; Lucy F Stead; Anjana Patel; Heiko Wurdak; Susan C Short
Journal:  Stem Cell Reports       Date:  2017-01-10       Impact factor: 7.765

9.  Inhibition of RAD51 by siRNA and Resveratrol Sensitizes Cancer Stem Cells Derived from HeLa Cell Cultures to Apoptosis.

Authors:  Graciela Ruíz; Heriberto A Valencia-González; Ismael León-Galicia; Enrique García-Villa; Alejandro García-Carrancá; Patricio Gariglio
Journal:  Stem Cells Int       Date:  2018-02-26       Impact factor: 5.443

10.  BRCA1 modulates the autophosphorylation status of DNA-PKcs in S phase of the cell cycle.

Authors:  Anthony J Davis; Linfeng Chi; Sairei So; Kyung-Jong Lee; Eiichiro Mori; Kazi Fattah; Jun Yang; David J Chen
Journal:  Nucleic Acids Res       Date:  2014-09-15       Impact factor: 16.971

View more
  8 in total

1.  Increased Yield of Residual γH2AX Foci in p53-Deficient Human Lung Carcinoma Cells Exposed to Subpicosecond Beams of Accelerated Electrons.

Authors:  N Yu Vorobyeva; N S Babayan; B A Grigoryan; A A Sargsyan; L G Khondkaryan; L S Apresyan; A K Chigasova; E I Yashkina; D V Guryev; S M Rodneva; A A Tsishnatti; Yu A Fedotov; R M Arutyunyan; A N Osipov
Journal:  Bull Exp Biol Med       Date:  2022-05-02       Impact factor: 0.804

Review 2.  Opposing Roles of Wild-type and Mutant p53 in the Process of Epithelial to Mesenchymal Transition.

Authors:  Oleg Semenov; Alexandra Daks; Olga Fedorova; Oleg Shuvalov; Nickolai A Barlev
Journal:  Front Mol Biosci       Date:  2022-06-23

3.  CD44+ and CD133+ Non-Small Cell Lung Cancer Cells Exhibit DNA Damage Response Pathways and Dormant Polyploid Giant Cancer Cell Enrichment Relating to Their p53 Status.

Authors:  Margarita Pustovalova; Taisia Blokhina; Lina Alhaddad; Anna Chigasova; Roman Chuprov-Netochin; Alexander Veviorskiy; Gleb Filkov; Andreyan N Osipov; Sergey Leonov
Journal:  Int J Mol Sci       Date:  2022-04-28       Impact factor: 6.208

Review 4.  Epithelial to Mesenchymal Transition: A Challenging Playground for Translational Research. Current Models and Focus on TWIST1 Relevance and Gastrointestinal Cancers.

Authors:  Luana Greco; Federica Rubbino; Alessandra Morelli; Federica Gaiani; Fabio Grizzi; Gian Luigi de'Angelis; Alberto Malesci; Luigi Laghi
Journal:  Int J Mol Sci       Date:  2021-10-25       Impact factor: 5.923

Review 5.  Curcuminoids as Modulators of EMT in Invasive Cancers: A Review of Molecular Targets With the Contribution of Malignant Mesothelioma Studies.

Authors:  Daniel L Pouliquen; Alice Boissard; Cécile Henry; Olivier Coqueret; Catherine Guette
Journal:  Front Pharmacol       Date:  2022-07-08       Impact factor: 5.988

6.  GATA3 Exerts Distinct Transcriptional Functions to Regulate Radiation Resistance in A549 and H1299 Cells.

Authors:  Rui Wang; Junxuan Yi; Hui Gao; Xinfeng Wei; Lihong Shao; Mingwei Wang; Weiqiang Xu; Xiaoshu Yin; Yannan Shen; Zhicheng Wang; Wei Wei; Shunzi Jin
Journal:  Oxid Med Cell Longev       Date:  2022-08-10       Impact factor: 7.310

Review 7.  Role of autophagy in tumor response to radiation: Implications for improving radiotherapy.

Authors:  Amrita Roy; Soumen Bera; Luciano Saso; Bilikere S Dwarakanath
Journal:  Front Oncol       Date:  2022-09-12       Impact factor: 5.738

Review 8.  Impact of One-Carbon Metabolism-Driving Epitranscriptome as a Therapeutic Target for Gastrointestinal Cancer.

Authors:  Yu Takeda; Ryota Chijimatsu; Andrea Vecchione; Takahiro Arai; Toru Kitagawa; Ken Ofusa; Masami Yabumoto; Takaaki Hirotsu; Hidetoshi Eguchi; Yuichiro Doki; Hideshi Ishii
Journal:  Int J Mol Sci       Date:  2021-07-06       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.